Year of publication
Type of media
Type of material
Licence
Language
1–20 of 131 hits
Sort by:
Sort by:
-
Synthesis and characterization of epoxide impurities of abiraterone acetate
Elsevier | 2022|Keywords: Abiraterone acetate, α-epoxy abiraterone acetate, β-epoxy abiraterone acetate -
Corticosteroid switch in heavily pre-treated castration-resistant prostate cancer patients progressed on abiraterone acetate plus prednisone
Online Contents | 2018|Keywords: abiraterone acetate -
Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration‐resistant prostate cancer
Wiley | 2015|Keywords: abiraterone acetate -
P2Y1 agonist HIC in combination with androgen receptor inhibitor abiraterone acetate impairs cell growth of prostate cancer
Free accessOnline Contents | 2022|Keywords: Abiraterone acetate -
Analytical challenges in quantifying abiraterone with LC–MS/MS in human plasma
Wiley | 2017|Keywords: abiraterone acetate -
Four-Step Synthesis of Abiraterone Acetate from Dehydroepiandrosterone
Online Contents | 2016|Keywords: abiraterone acetate -
Exosomal TUBB3 mRNA expression of metastatic castration‐resistant prostate cancer patients: Association with patient outcome under abiraterone
Free accessWiley | 2021|Keywords: abiraterone acetate -
The impact of statin use on the efficacy of abiraterone acetate in patients with castration‐resistant prostate cancer
Wiley | 2017|Keywords: abiraterone acetate -
Toxicity profile characteristics of novel androgen-deprivation therapy agents in patients with prostate cancer: a meta-analysis
Taylor & Francis Verlag | 2018|Keywords: Abiraterone acetate -
Targeting backdoor androgen synthesis through AKR1C3 inhibition: A presurgical hormonal ablative neoadjuvant trial in high‐risk localized prostate cancer
Wiley | 2021|Keywords: abiraterone acetate -
Abiraterone acetate for the treatment of prostate cancer
Taylor & Francis Verlag | 2013|Keywords: abiraterone acetate -
Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC).
Free accessBASE | 2014|Keywords: Abiraterone acetate -
Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration‐resistant prostate cancer
Wiley | 2023|Keywords: abiraterone acetate -
Synthesis and Characterization of API‐Related Substances in Abiraterone Acetate **
Wiley | 2023|Keywords: Abiraterone acetate -
Abiraterone acetate: a potential source of interference in testosterone assays
DeGruyter | 2018|Keywords: abiraterone acetate -
Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy
Taylor & Francis Verlag | 2018|Keywords: abiraterone acetate -
Abiraterone acetate versus nonsteroidal antiandrogen with androgen deprivation therapy for high‐risk metastatic hormone‐sensitive prostate cancer
Wiley | 2022|Keywords: abiraterone acetate
Send my search to (beta)
Send your search query (search terms without filters) to other databases, portals and catalogues to find more interesting hits.
Dimensions:
full data search
or
title and abstract search
Dimensions is a database for abstracts and citations that links information on research funding with the resulting publications, studies and patents.
TIB AV portal
In the TIB AV-Portal, audiovisual media from science and teaching can be foundand own scientific videos can be published.
Specialised Information Service for Mobility and Transport Research (FID move)
Open Research Knowledge Graph (ORKG)
The FID move can be used to search for subject-specific literature, research data and other information from mobility and transport research.
The Open Research Knowledge Graph provides structured descriptions of research content and makes it comparable.
Common Union Catalogue (GVK)
Freely accessible part of the collaborative K10plus catalogue with materials relevant for interlibrary loan and direct delivery services.